Dan Zhang, MD, MPHExecutive Chairman at Fountain Medical Development Ltd
Profile
Before founding Fountain Medical Development Ltd. In 2007, Dr. Zhang was the Head of Clinical Development and Safety Assessment at Sigma-Tau Research Inc. Prior to that he was the Vice President at the Quintiles Transnational Corp. and Chairman of Quintiles Medical Development (Shanghai) Company Ltd.
Dr. Zhang is a member of grant review committee for National Drug Development Fund of China, and is also a consultant for the National Medical Products Administration (NMPA). He is a member of ICH E19 Expert Working Group. He was a member of the Overseas Expert Committee on New Drug R&D for the Ministry of Science and Technology of China, and was the secretary-general of the Association of “Thousand Talent” Expert from 2011-2017. Dr. Zhang was the former board of director for the Sino-American Pharmaceutical Association (SAPA) and was the former president of Chinese Biopharmaceutical Association-USA (CBA), Dr. Zhang is chairing the government relationship committee of Bayhelix - an organization hosting senior executives from life science organizations in USA and China.